15899558 27522177 30717485 25613718 22753957 17141431 18295907 29789450 20210778 36298582 18826508 29956186 33809232 26638898 29263258 17314517 20167521 17706778 26802606 23800540 26553450 21956500 23749359 - Search Results

Year	Number of Results
2005	1
2006	1
2007	3
2008	3
2010	2
2012	2
2013	2
2014	1
2015	3
2016	4
2018	3
2019	1
2021	1
2022	1
2023	0

1

Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected cats.

Kusuhara H, Hohdatsu T, Okumura M, Sato K, Suzuki Y, Motokawa K, Gemma T, Watanabe R, Huang C, Arai S, Koyama H. Kusuhara H, et al. Vet Microbiol. 2005 Jul 1;108(3-4):155-65. doi: 10.1016/j.vetmic.2005.02.014. Vet Microbiol. 2005. PMID: 15899558

2

The protective rate of the feline immunodeficiency virus vaccine: An Australian field study.

Westman ME, Malik R, Hall E, Harris M, Norris JM. Westman ME, et al. Vaccine. 2016 Sep 7;34(39):4752-4758. doi: 10.1016/j.vaccine.2016.06.060. Epub 2016 Aug 10. Vaccine. 2016. PMID: 27522177

3

Immunogenicity and Efficacy of a Novel Multi-Antigenic Peptide Vaccine Based on Cross-Reactivity between Feline and Human Immunodeficiency Viruses.

Sahay B, Aranyos AM, Mishra M, McAvoy AC, Martin MM, Pu R, Shiomitsu S, Shiomitsu K, Dark MJ, Sanou MP, Roff SR, Rathore MH, Yamamoto JK. Sahay B, et al. Viruses. 2019 Feb 3;11(2):136. doi: 10.3390/v11020136. Viruses. 2019. PMID: 30717485 Free PMC article.

4

Neutralising antibody response in domestic cats immunised with a commercial feline immunodeficiency virus (FIV) vaccine.

Bęczkowski PM, Harris M, Techakriengkrai N, Beatty JA, Willett BJ, Hosie MJ. Bęczkowski PM, et al. Vaccine. 2015 Feb 18;33(8):977-84. doi: 10.1016/j.vaccine.2015.01.028. Epub 2015 Jan 19. Vaccine. 2015. PMID: 25613718 Free PMC article.

5

Feline leukemia and feline immunodeficiency virus in Canada - A comment.

Doornenbal E, Ingwersen W, Cloutier G. Doornenbal E, et al. Can Vet J. 2012 Jan;53(1):9-10; author reply 10. Can Vet J. 2012. PMID: 22753957 Free PMC article. No abstract available.

6

Serological differentiation of FIV-infected cats from dual-subtype feline immunodeficiency virus vaccine (Fel-O-Vax FIV) inoculated cats.

Kusuhara H, Hohdatsu T, Seta T, Nemoto K, Motokawa K, Gemma T, Watanabe R, Huang C, Arai S, Koyama H. Kusuhara H, et al. Vet Microbiol. 2007 Mar 10;120(3-4):217-25. doi: 10.1016/j.vetmic.2006.10.038. Epub 2006 Dec 1. Vet Microbiol. 2007. PMID: 17141431

7

Advances in FIV vaccine technology.

Uhl EW, Martin M, Coleman JK, Yamamoto JK. Uhl EW, et al. Vet Immunol Immunopathol. 2008 May 15;123(1-2):65-80. doi: 10.1016/j.vetimm.2008.01.030. Epub 2008 Jan 20. Vet Immunol Immunopathol. 2008. PMID: 18295907 Free PMC article. Review.

8

Lessons Learned in Developing a Commercial FIV Vaccine: The Immunity Required for an Effective HIV-1 Vaccine.

Sahay B, Yamamoto JK. Sahay B, et al. Viruses. 2018 May 22;10(5):277. doi: 10.3390/v10050277. Viruses. 2018. PMID: 29789450 Free PMC article. Review.

9

Feline immunodeficiency virus model for designing HIV/AIDS vaccines.

Yamamoto JK, Sanou MP, Abbott JR, Coleman JK. Yamamoto JK, et al. Curr HIV Res. 2010 Jan;8(1):14-25. doi: 10.2174/157016210790416361. Curr HIV Res. 2010. PMID: 20210778 Free PMC article. Review.

10

Developing a Feline Immunodeficiency Virus Subtype B Vaccine Prototype Using a Recombinant MVA Vector.

Andrade LAF, Versiani AF, Barbosa-Stancioli EF, Dos Reis JKP, Dos Reis JGAC, da Fonseca FG. Andrade LAF, et al. Vaccines (Basel). 2022 Oct 14;10(10):1717. doi: 10.3390/vaccines10101717. Vaccines (Basel). 2022. PMID: 36298582 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results